October 20, 2014
ZYGO Series—PHARMACEUTICAL ACCESS: Global Drug Management and Underserved Populations
Friday, October 24, 2014, DML 241 | 12:30 PM – 1:30 PM | Lunch Provided
Co-sponsored by the Levan Institute for Humanities and Ethics and the Sidney Harman Academy for Polymathic Study
Moderator: Sucharita Yellapragada, ZYGO Student Program Manager
Jeff McCombs, Associate Professor and Director of Graduate Studies, Clinical Pharmacy and Pharmaceutical Economics & Policy, USC Schaeffer
Erin Quinn, Associate Dean for Science and Health, USC Dornsife
Heather Wipfli, Associate Director, USC Institute for Global Health and Assistant Professor, Department of Preventative Medicine and School of International Relations, USC Keck School of Medicine
The pharmaceutical industry is frequently criticized as being focused entirely on making a profit and not truly caring for the well-being of the people. This seminar will seek to explore if pharmaceutical companies have any ethical obligations towards underserved populations, or if, like any other company, they ultimately serve as a means of improving the economy of their local community. After the Agreement of Trade-Related Aspects of Intellectual Property Rights was passed by the World Trade Organization in 1996, countries were able to apply for compulsory licenses through which they could produce generic copies of these drugs without the permission of the patent owner. Since 2003, compulsory license holders can also export generic drugs to other countries that lack production capabilities. Panelists will consider if compulsory licenses are an ethical obligation for pharmaceutical companies and if this system adequately gives credit to the initial patent holder.
The ZYGO Series is organized by USC students in health and medicine who seek dialogue with USC faculty across disciplines in order to increase the integration of ethical themes into their curriculum.
zygo / ˈzʌɪgəʊ, ˈzɪgəʊ / pref. relating to union or joining